Evidence map›Paper›PMID 25248126›Full record

ArticlePloS one2014

N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression.

Yu-Hsuan Lee, Shih-Bin Su, Chien-Cheng Huang, Hamm-Ming Sheu, Jui-Chen Tsai, Chia-Ho Lin, Ying-Jan Wang, Bour-Jr Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Modulation of Autophagy on Cinnamaldehyde Induced THP-1 Cell Activation.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Tattoo inks: evaluation of cellular responses and analysis of some trace metals.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yu-Hsuan LeeDepartment of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan.
Shih-Bin SuDepartment of Occupational Medicine, Chi-Mei Medical Center, Tainan, Taiwan; Department of Leisure, Recreation and Tourism Management, Southern Taiwan University of Science and Technology, Tainan, Taiwan; Department of Medical Research, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Chien-Cheng HuangDepartment of Emergency Medicine, Chi-Mei Medical Center, Tainan, Taiwan; Department of Child Care and Education, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
Hamm-Ming SheuDepartment of Dermatology, National Cheng Kung University Medical College, Tainan, Taiwan.
Jui-Chen TsaiInstitute of Clinical Pharmacy, National Cheng Kung University, Tainan, Taiwan.
Chia-Ho LinDivision of Urology, Department of Surgery, Chi Mei Medical Center, Liouying, Taiwan; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
Ying-Jan WangDepartment of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan; Department of Biomedical Informatics, Asia University, Taichung, Taiwan.
Bour-Jr WangDepartment of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan; Department of Cosmetic Science and Institute of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
National Cheng Kung University · TWSouthern Taiwan University of Science and Technology · TWAsia University · TWChi Mei Medical Center · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromium hypersensitivity (chromium-induced allergic contact dermatitis) is an important issue in occupational skin disease. Hexavalent chromium (Cr (VI)) can activate the Akt, Nuclear factor κB (NF-κB), and Mitogen-activated protein kinase (MAPK) pathways and induce cell death, via the effects of reactive oxygen species (ROS). Recently, cell death stimuli have been proposed to regulate the release of inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1). However, the exact effects of ROS on the signaling molecules and cytotoxicity involved in Cr(VI)-induced hypersensitivity have not yet been fully demonstrated. N-acetylcysteine (NAC) could increase glutathione levels in the skin and act as an antioxidant. In this study, we investigated the effects of NAC on attenuating the Cr(VI)-triggered ROS signaling in both normal keratinocyte cells (HaCaT cells) and a guinea pig (GP) model. The results showed the induction of apoptosis, autophagy and ROS were observed after different concentrations of Cr(VI) treatment. HaCaT cells pretreated with NAC exhibited a decrease in apoptosis and autophagy, which could affect cell viability. In addition, Cr (VI) activated the Akt, NF-κB and MAPK pathways thereby increasing IL-1α and TNF-α production. However, all of these stimulation phenomena could be inhibited by NAC in both of in vitro and in vivo studies. These novel findings indicate that NAC may prevent the development of chromium hypersensitivity by inhibiting of ROS-induced cell death and cytokine expression.

Indexed as

AcetylcysteineAnimalsAntioxidantsApoptosisAutophagyCells, CulturedChromiumDermatitis, Allergic ContactDrug Evaluation, PreclinicalFemaleGene Expression RegulationGuinea PigsInterleukin-1alphaKeratinocytesMAP Kinase Signaling SystemNF-kappa BAcetylcysteineAntioxidantsChromiumchromium hexavalent ionInterleukin-1alphaNF-kappa BOncogene Protein v-aktReactive Oxygen SpeciesRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID25248126
PMCPMC4172727
OpenAlexW2060699633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.